A recent study found there were BETTER short-term outcomes among women with:
• triple-negative breast cancer and BRCA1 or BRCA2 mutations
• ovarian cancer and BRCA2, BRIP1, RAD51C, or ATM mutations
These findings may be reassuring to individuals with inherited gene mutations related to breast and ovarian cancer. Read the article to learn more!
https://pubmed.ncbi.nlm.nih.gov/34373918/
Reference: Kurian et al. J Natl Cancer Inst. 2021 Aug 9;djab151. PMID: 34373918.